Safety and tolerability of North American ginseng extract in the treatment of pediatric upper respiratory tract infection: a phase II randomized, controlled trial of 2 dosing schedules.

@article{Vohra2008SafetyAT,
  title={Safety and tolerability of North American ginseng extract in the treatment of pediatric upper respiratory tract infection: a phase II randomized, controlled trial of 2 dosing schedules.},
  author={Sunita Vohra and Bradley C. Johnston and Keri L Laycock and William K. Midodzi and Indra Dhunnoo and Evan J Harris and Lola Baydala},
  journal={Pediatrics},
  year={2008},
  volume={122 2},
  pages={e402-10}
}
BACKGROUND Upper respiratory tract infections are the most common childhood illness. Panax quinquefolius (American ginseng root extract) standardized to contain 80% poly-furanosyl-pyranosyl-saccharides is purported to be effective in adult upper respiratory tract infection but has not been evaluated yet in a pediatric population. OBJECTIVES Our primary… CONTINUE READING